Africa

Whale sharks, the largest of living sharks, filter-feed on plankton and other small marine creatures, which they suck into their open mouths as they swim. Credit: Enric Sala, National Geographic Pristine Seas

By Enric Sala
WASHINGTON DC, Jan 10 2022 (IPS)

There is no other place in the world like Costa Rica’s Cocos Island National Park. The waters surrounding the island–covered with tropical forests–are a playground to countless shivers, or schools, of sharks, including hammerhead sharks, whitetip reef sharks and whale sharks.

Also boasting rays, turtles, whales and dolphins, It’s one of the world’s most biodiverse waterways. In recent years, however, industrial fishing activity has encroached on the area, threatening this unparalleled marine life.

Fortunately, Costa Rica took decisive action this month by expanding the protected waters by 27 times. They also protected an additional marine area–the Bicentennial Marine Managed Area, which is twice the size of the expanded Cocos Island National Park. The area includes no take zones and will closely monitor fishing activity.

Stories like this one are all too rare. In the last century alone, we have removed over 90% of the ocean’s large fish, yet less than 8% of the ocean is under some kind of protection. We’re still learning about the collateral damage from destructive fishing activities, like bottom trawling, which scrape up the ocean floor—the world’s largest carbon storehouse.

It’s clear that commercial fishing, global warming and pollution have decimated the ocean. Few corners of the vast ocean are safe. As a result, the seas are losing their ability to safeguard biodiversity, provide food and store carbon—all of which are critical to maintaining a livable planet, which was under intense discussion at the climate talks in Glasgow late last year.

But it is possible to restore the ocean’s benefits to people and the planet. All we must do is rewild the sea. The only catch is that we can’t wait. We have less than a decade to act.

Since 2018, I have worked around the clock and around the world with a team of scientists to identify which areas of the ocean we must protect first. We have discovered through our research and countless expeditions the trade-offs among the ocean’s benefits.

To support our work, we developed a framework that could help us maximize the benefits that humanity obtains from the ocean. We found that if we were to give equal importance to biodiversity, food and carbon, it is imperative to protect 45% of the ocean – the “right” 45%.

Even if we decided that biodiversity is not so important, we would need to protect 30%–the minimum area needed to preserve marine life and all of the benefits it provides to people.

Costa Rica is part of a growing group of world leaders that understand the benefits of protecting marine areas. At the Glasgow climate talks, Costa Rica, together with Colombia, Ecuador, and Panama, announced their commitment to create more marine reserves in the Eastern Tropical Pacific.

Establishing no-take areas along an “ocean highway” for migratory species such as tuna will actually increase fish supplies in the surrounding areas. As a result, biodiversity and economies benefit.

Earlier this month, the government of Portugal expanded a marine protected area around the Selvagens Islands, located midway between Madeira and Canary Islands. At 3,677 square kilometers, the area is now the largest fully protected marine reserve in Europe.

Countries worldwide must establish more of these protected areas by 2030 if we are to ensure that the ocean can continue to provide us with its benefits. Protections must be strong. Marine protected areas can only work their magic if all fishing and other damaging human activities are banned—and these rules are enforced.

So far, 77 countries have agreed to champion a global goal to protect 30% of the ocean—and well as land—by 2030. They are pushing to ensure that the 30×30 target is enshrined in a global UN biodiversity agreement, under negotiation now and expected to be signed in 2022.

But the world doesn’t have to wait for the ink to dry on the agreement to establish more marine protected areas. Too much is at stake. I have seen with my own eyes how nature recovers in marine reserves. More importantly, I have seen how this return of nature has helped people gain better lives.

Enric Sala is an Explorer in Residence at the National Geographic Society, the founder of Pristine Seas, and the recipient of this year’s Prince Albert I Grand Medal for his work to protect the ocean. Pristine Seas has helped to establish 24 marine protected areas, covering a total area of more than 6.5 million square kilometers — more than twice the size of India.

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');  

Hosts Cameroon come from behind to beat Burkina Faso in an absorbing opening game at the Africa Cup of Nations.

Live coverage of Sunday's opening game at the Africa Cup of Nations, the Group A clash between Cameroon and Burkina Faso (16:00 GMT).

Goalkeeper Edouard Mendy and captain Kalidou Koulibaly will miss Senegal's opening Africa Cup of Nations game after testing positive for coronavirus.

The attacks in the northern Zamfara state are believed to be in response to military air strikes.

Africa's top football tournament is about to start in Cameroon, despite a bitter four-year conflict.

Countries suffering Covid outbreaks will still have to play their Africa Cup of Nations matches if they have 11 players available.

After serving a nine-month doping ban last year, Cameroon goalkeeper Andre Onana is confident of success at the Africa Cup of Nations.

Aid workers in northern Ethiopia say 56 people are killed in a strike on a camp for the displaced.

Prime Minister Abiy Ahmed says the prisoners are being released in a bid to promote reconciliation.

Kenyans called for a KFC boycott after it was discovered that its fries were imported from Egypt.

The Africa Cup of Nations should "100% be more respected", says Nigeria captain William Troost-Ekong.

The suspects had been detained at sea in the Gulf of Guinea in November. A fourth remains in custody.

Video assistant referees (VAR) will be used at all 52 matches at this month's Africa Cup of Nations.

Christine Mboma, who became the first Namibian woman to win an Olympic medal, is the BBC African Sports Personality of the Year for 2021.

The alarm did not work and fire doors were left open when Sunday's blaze started, the fire service says.

Egypt delay their departure for the Africa Cup of Nations in Cameroon after coronavirus cases were reported in their camp.

The key, kept by a former guard, was going to be auctioned in the US until South Africa objected.

Community support workers are key in raising awareness about TB and promoting diagnosis and treatment. Credit, Busani Bafana/IPS

By Busani Bafana
BULAWAYO, Zimbabwe, Jan 7 2022 (IPS)

Global efforts to end tuberculosis (TB) are futile without dedicated investment in research into the debilitating disease that is killing 4000 people a day, Stop TB Partnership warns.

“TB is a disease that is not a darling of donors and investors,” Lucica Ditiu, the Executive Director of the Stop TB Partnership, told IPS in an interview from Geneva.

“We do not have a Bill Gates that can support TB research, yet TB remains a disease of concern with deaths increasing for the first time in over a decade,” she added.

TB, a bacterial disease mainly affecting the lungs, has been around for over millennia and remains one of the top killer diseases globally. But it is preventable and curable with the right investment in diagnosis and treatment.

Ditiu attributed the rise in TB incidents to several factors; many people diagnosed and on treatment for TB have defaulted owing to the disruption of health services in the wake of the COVID-19 pandemic and global lockdown. Furthermore, many people remain undiagnosed because they have not been reached.

Dr Lucica Ditiu, Executive Director of the Stop TB Partnership. Credit: Stop TB Partnership

“Southern Africa has done a good job in respect of Zambia, Zimbabwe and South Africa as well as Rwanda in trying to disrupt as little as possible the treatment and diagnosis of people with TB,” Ditiu said. She commended awareness programmes in the media and community door-to-door campaigns to promote diagnosis and treatment.

Countries need to invest more in finding people with TB and putting them on treatment. Until you find people, you cannot put them on treatment, and this is where we are very much lagging, she said.

Ditiu fears the worst should the world fail to change the current TB transmission trend. An estimated 5.8 million people received treatment for TB in 2020; a drop of 21 percent from 2019, and more than 4 million people worldwide remain untreated. According to Stop TB Partnership, half of those untreated are likely to die from the disease.

Admitting that funding for TB has always been insufficient, Ditiu said TB was the poor cousin compared to the deep pockets for HIV and AIDS.

“In general, we have available only 30 percent of the funding needed globally. We have places that have done well in preventing TB in people living with HIV. Prevention of TB in people living with HIV is going well, especially in African countries because HIV has resources.”

According to the Stop TB Partnership, a network of international organisations established in 1998 to help end TB as a public health problem, funding for TB research and development (R&D) has remained flat since 2018.

Global funding for tuberculosis (TB) research totalled 915 million US dollars in 2020 – less than half the goal of 2 billion US dollars set forth by participating country governments at the 2018 United Nations High-Level Meeting on TB.

In 2021, TB had a funding gap of 13 billion US dollars globally, with only 5,3 billion US dollars available for its programmes. It experienced a drop in funding amounting to 500 000 US dollars in 2020 as many countries took money away from TB to respond to COVID-19.

A new report, Tuberculosis Research Funding Trends, 2005–2020 by Treatment Action Group (TAG) and the Stop TB Partnership, found that TB received less than 1 percent of the amount invested in COVID-19 Research and Development over the first 11 months of the pandemic.

“The mobilisation of over 100 billion US dollars for COVID-19 research and development in the first 11 months of the pandemic shows us just how powerful a coordinated effort against a disease can be,” noted Ditiu.

While the pandemic has shown that effective vaccines can save lives, the world is still banking on a 100-year-old vaccine, Bacillus Calmette-Guérin or BCG. However, a more effective vaccine could have higher efficacy rates, especially for adults. Why has it taken so long to develop a new, more effective TB vaccine when the health burden of TB is increasing?

“This is the drama,” Ditiu commented. “We have a vaccine for a hundred years that we know for the last 40 years does not work (effectively) except for newly-born babies, and yet we have not done much about it.”

While ongoing research on new vaccines had been slow because of poor funding, Ditiu said several potential vaccines were in the pipeline, and a vaccine could be expected by 2027.

“It takes a long time to get a vaccine. But because of COVID (we realised), it is possible to have a vaccine much quicker, and we hope to use the learnings from COVID-19 to get a TB vaccine,” Ditiu told IPS.

Tuberculosis vaccine research has been slowed by chronic underfunding with only one moderately effective century-old TB vaccine, compared to over 20 COVID-19 vaccines.

“What’s enabled the development of dozens of COVID-19 vaccines in less than a year has essentially been money,” noted Austin Aurinze Obiefuna, Executive Director of the Afro Global Health Alliance and incoming Vice-Chair of the Stop TB Partnership Board.

“I think that the same enormous amount of funding should be applied with equal vigour to the development of TB vaccines. But that simply doesn’t seem to be happening.”

According to the Stop TB Partnership, making much-needed progress against TB demands investment that matches the threat of the disease around the world. This includes a commitment to rectify the inadequate funding of the past. Over the next two years, 10 billion US dollars are needed to close the tuberculosis R&D funding gap.

“Wealthy countries need to step up and put more money into correcting global health inequalities, which COVID-19 vaccine allocation inequities laid bare,” urged Mark Harrington, Executive Director of TAG, an independent activist, and community-based research and policy think tank.

“COVID-19 made more people around the world aware of the importance of R&D spending than ever before. Now is the time to finally start making investments ambitious enough to end TB for good.”

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   Related Articles

• Tuberculosis Kills As Many People Each Year As COVID-19. It’s Time We Found a Better Vaccine
• In Sub-Saharan Africa and Elsewhere, We Need to Look Harder for Tuberculosis
• http://www.ipsnews.net/2022/01/activism-will-key-overcoming-covid-19-crisis/

Protest sign, London. Credit: People’s Vaccine Alliance

By Ben Phillips
ROME, Jan 7 2022 (IPS)

As the Omicron surge overwhelms the world, it is clear to people everywhere that the actions which leaders so far have taken in response to the Covid-19 crisis have not been sufficient to overcome it.

We are not beating Covid. It looks rather like Covid is beating us. What is to be done?

Crucially, they are two key dimensions to what is needed now which, though related, are distinct. The first dimension is what policies are required to get us out of the crisis. The second dimension is how to get those policies put into place.

In other words, the first key question is “what do leaders need to do?”, and the second key question is “how do we make them do it?”

On the first question, the world is fortunate that we are not short of excellent public health expertise. Whilst there are no quick fixes, the contours of the policies required are not a mystery, and have been set out, to leaders and to media, repeatedly, by the World Health Organisation, by leading academics, and by health practitioners.

They come down essentially to this: in a pandemic emergency, leaders need to deploy the whole range of tools that have been shown to help. The key here is the whole range.

Importantly, in terms of how these approaches can be realized, this requires that they are realized for the whole world. Until they do, none of us will get out of the crisis. When Desmond Tutu said that “I am because you are, I am because we are”, that was not only true ethically, but, it turns out, true epidemiologically too.

The approaches required include vaccines, treatments, and also, as the WHO’s Peter Singer has noted, “public health measures that encourage spending time outdoors, physical distancing, wearing masks, rapid testing, limiting gatherings and staying home when sick”.

None of these alone is enough. Any approach that only does one of these, however well, would fail – all of them are needed, together.

It requires the application of the whole range of policy tools. For example, rich countries, and Foundations based in rich countries, have emphasized the importance of sharing doses as a solution (even whilst they have comprehensively failed to deliver on their promises to do so).

In contrast, developing countries, the World Health Organisation and civil society have all highlighted that sharing doses alone cannot ensure enough for everyone, and that it is essential also to share the technology so that multiple producers across the world can simultaneously manufacture enough to vaccinate the world.

This requires rapid agreement and implementation of the TRIPS Waiver proposed by South Africa and India at the WTO, and it also requires that rich country governments use their huge leverage (as procurers, investors and regulators) over the companies they host to make them share knowledge, know-how and material. Furthermore, this requirement to share Covid technologies needs to apply to vaccines, medicines and diagnostics.

As public health professors Madhukar Pai of McGill and Manu Prakash of Stanford have noted, “Science has delivered many tools that work against Covid-19. But equitable distribution of these tools is where we are failing.

If we can find a way to share effective tools equitably and increase their production across the world, then we have a real shot at ending this pandemic.

If we hoard these tools, block TRIPS waiver, and think we can boost our way out of this pandemic in the global North, we will begin 2023 by playing whack-a-mole with the rho, sigma, tau or Omega variants.”

The challenge then, is not that we don’t know what leaders need to do. The challenge is that they are not doing it. We like to believe that our leaders are led by the evidence. But evidence alone is not enough.

The brilliant and essential reports of scientists will not be enough to shift the much harsher world of political interests. Getting leaders to do what is needed to overcome the Covid-19 crisis – in particular getting leaders to force the big pharmaceutical companies to share the rights and recipes for the vaccines, therapeutics and diagnostics so the world can produce the billions needed – will depend on pressure from ordinary people.

This is not a new lesson. We saw it in the late 1990s and early 2000s with antiretrovirals for HIV. Then, as now, a monopoly hold on production was preventing people in developing countries from accessing life-saving help.

Then, as now, the big pharmaceutical companies worked aggressively to block other producers from manufacturing what would save millions of lives. Then, as now, rich country governments sided with the big pharmaceutical companies. Twelve million people died. Finally, massive global public pressure, together with assertive action by developing countries, ensured that production was opened up and lives could be saved.

It was not a coincidence that when the Covid-19 crisis erupted the first groups to call for the sharing of medical technologies, and to start to organise for it, were groups of people living with HIV. They are the heart of the movement for a People’s Vaccine because, from painful experience, they know what it takes. Health, like justice, is never given; it is only ever won.

Some people are inspired by activism. Others, understandably, just want to get on with their lives. Activism feels like another burden. They’re ready to do their part by wearing a mask when available and getting vaccinated when offered. But they want to leave the leadership to our leaders.

The thing is, that’s not enough. Our leaders are not leading. They are not doing all they can to end the crisis. They are not forcing the big pharmaceutical companies to share technologies so that enough can be produced. They are not ensuring access to health care as right. They are not protecting the vulnerable from the shock of the crisis.

The past two years can best be summed up like this: the science is working, but the politics is failing.

It is only through bold action by political leaders that the Covid-19 crisis will be ended. It is only through people’s organising that we’ll make leaders take that bold action. As the great novelist Alice Walker once put it so powerfully, “activism is the rent we pay for living on the planet”.

Ben Phillips is the author of ‘How to Fight Inequality’ and an advisor to the United Nations, governments and civil society organisations (CSOs).

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');